Home Cart Sign in  
Chemical Structure| 423768-52-9 Chemical Structure| 423768-52-9

Structure of 423768-52-9

Chemical Structure| 423768-52-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 423768-52-9 ]

CAS No. :423768-52-9
Formula : C6H11N3
M.W : 125.17
SMILES Code : NCC1=NN(C)C(C)=C1
MDL No. :MFCD03422531
InChI Key :JGYXJOBBROGMLL-UHFFFAOYSA-N
Pubchem ID :2776367

Safety of [ 423768-52-9 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 423768-52-9 ] Show Less

Physicochemical Properties

Num. heavy atoms 9
Num. arom. heavy atoms 5
Fraction Csp3 0.5
Num. rotatable bonds 1
Num. H-bond acceptors 2.0
Num. H-bond donors 1.0
Molar Refractivity 36.13
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

43.84 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.48
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

-0.47
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.04
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.16
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.35
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.25

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.67
Solubility 27.1 mg/ml ; 0.216 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

0.02
Solubility 130.0 mg/ml ; 1.04 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Highly soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.19
Solubility 8.14 mg/ml ; 0.065 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.4 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.63

Application In Synthesis of [ 423768-52-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 423768-52-9 ]

[ 423768-52-9 ] Synthesis Path-Downstream   1~21

  • 1
  • [ 423768-52-9 ]
  • [ 872423-48-8 ]
  • C29H31N4O2P [ No CAS ]
  • 2
  • [ 423768-52-9 ]
  • [ 872423-49-9 ]
  • (1R,2R)-2-((R)-diphenylphosphinylamino)phenyl(methyl)cyclopropane carboxylic acid (1,5-dimethyl-1H-pyrazol-3-ylmethyl)amide [ No CAS ]
  • 3
  • [ 423768-52-9 ]
  • [ 4774-14-5 ]
  • 2-[(1,5-dimethyl-1H-pyrazol-3-yl)methylamino]-6-chloropyrazine [ No CAS ]
  • 4
  • [ 423768-52-9 ]
  • [ 1027039-32-2 ]
  • [ 950598-91-1 ]
  • 5
  • [ 423768-52-9 ]
  • 2-[(1,5-dimethyl-1H-pyrazol-3-yl)methylamino]-6-(3-acetamidophenyl)pyrazine [ No CAS ]
  • 6
  • [ 423768-52-9 ]
  • [ 75-44-5 ]
  • [ 1034257-10-7 ]
  • [ 1034257-58-3 ]
  • 7
  • [ 423768-52-9 ]
  • [ 1203605-21-3 ]
  • [ 1203604-47-0 ]
YieldReaction ConditionsOperation in experiment
59% With potassium carbonate; In acetonitrile; at 85℃;Inert atmosphere; Under argon, a solution of 3-chloro-5-(2,6-dimethoxyphenyl)-1,2,4-triazine (6.85 mg, 0.027 mmol, prepared as in example 41), <strong>[423768-52-9](1,5-dimethyl-1H-pyrazol-3-yl)methylamine</strong> (8 mg, 0.064 mmol) and potassium carbonate (3.8 mg, 0.028 mmol) in anhydrous acetonitrile (0.7 mL) was stirred at 85C overnight. The solution was evaporated. The residue was purified by preparative TLC (silica gel, dichloromethane/methanol 95/5) to afford 5-(2,6-dimethoxyphenyl)-N-[(1,5-dimethyl-1H-pyrazol-3-yl)methyl]-1,2,4-triazin-3-amine (5.5 mg, 59%) as an off-white solid. ESI-MS m/z 341 (M+H)+. 1H NMR (CDCl3), delta (ppm): 8.45 (s, 1H), 7.40 (t, J = 8.4 Hz, 1H), 6.64 (d, J = 8.4 Hz, 2H), 6.06 (s, 1H), 4.70 (d, J = 5.2 Hz, 2H), 3.77 (s, 6H), 3.73 (s, 3H), 2.23 (s, 3H).
  • 8
  • [ 5744-59-2 ]
  • [ 423768-52-9 ]
  • 9
  • [ 54384-74-6 ]
  • [ 423768-52-9 ]
YieldReaction ConditionsOperation in experiment
31% With lithium aluminium tetrahydride; In tetrahydrofuran; at 0℃;Reflux; To the above product (5 g, 35.97 mmol) in THF (70 mL) was added LiAlH4 (4.1 g, 107.89 mmol) in several batches at 00C. The resulting solution was refluxed for 1 hr. The solids were filtered out and the filtrate was concentrated, resulted in 3 g (67%) of 1,5- dimethyl-lH-pyrazol-3-yl)methanamine as yellow oil.
  • 10
  • [ 423768-52-9 ]
  • [ 1196886-61-9 ]
  • 11
  • [ 423768-52-9 ]
  • [ 1196882-72-0 ]
  • 12
  • [ 423768-52-9 ]
  • [ 1196886-63-1 ]
  • 13
  • [ 423768-52-9 ]
  • [ 1196882-74-2 ]
  • 14
  • [ 423768-52-9 ]
  • [ 848694-76-8 ]
  • [ 1196886-59-5 ]
YieldReaction ConditionsOperation in experiment
31% With triethylamine; In ethanol; for 3h;Reflux; To a solution of ethyl 2-(2-amino-4,6-dichloropyrimidin-5-yl)acetate (200 mg, 0.80 mmol) in EtOH (30 mL) was added (l,5-dimethyl-lH-pyrazol-3-yl)methanamine (300 mg, 2.40 mmol) and Et3N (400 mg, 3.96 mmol). The resulting solution was refluxed for 3 hours. The reaction mixture was concentrated under vacuum. The residue was purified on a silica gel column with DCMrMeOH (50:1), resulted in 0.25 g (31%) of ethyl 2-(2-amino-4-chloro- 6-((l,5-dimethyl-lH-pyrazol-3-yl) methylamino)pyrimidin-5-yl)acetate as a yellow solid
  • 15
  • [ 423768-52-9 ]
  • [ 1393598-51-0 ]
  • [ 1393598-41-8 ]
  • 16
  • [ 423768-52-9 ]
  • [ 10035-16-2 ]
  • [ 1185322-46-6 ]
YieldReaction ConditionsOperation in experiment
63% To a solution of benzofuran-5-carbaldehyde (526 mg, 3.6 mmol, 1.2 equiv) in MeOH (15 mL) were added NaOAc (246 mg, 3.0 mmol, 1.0 equiv), HOAc (172 muL, 3.0 mmol, 1.0 equiv) and (l,5-dimethyl-l-pyrazole-3-yl)methylamine (376 mg, 3.0 mmol, 1.0 equiv., available from Maybridge). The mixture was stirred at room temperature for 5 min, and then treated with NaBH4 (273 mg, 7.2 mmol, 2.4 equiv) at 0 0C. The resulting mixture <n="52"/>was allowed to return to room temperature and stirred for 1 h, after which time the reaction was quenched with IN NaOH. The mixture was concentrated in vacuo to remove most of the MeOH, and the water layer was extracted with ethyl acetate three times. The combined organic phase was dried over Na2SO4, filtered and concentrated in vacuo. The residue was purified on silica gel with ethyl acetate/dichloromethane/methanol 5/5/1 as eluant to afford l-(Benzofuran-5-yl)-N-((l,5-dimethyl-lH-pyrazol-3-yl)methyl)methanamine (478 mg, 63%). MS 256 (MH)+. Purity 95% (HPLC)
  • 17
  • [ 423768-52-9 ]
  • [ 1007876-34-7 ]
  • 18
  • [ 423768-52-9 ]
  • [ 1185321-73-6 ]
  • 19
  • [ 423768-52-9 ]
  • C15H16ClN3O2 [ No CAS ]
  • C21H26N6O2 [ No CAS ]
  • 20
  • [ 423768-52-9 ]
  • C15H16ClN3O3 [ No CAS ]
  • C21H26N6O3 [ No CAS ]
  • 21
  • [ 423768-52-9 ]
  • C14H13ClFN3O2 [ No CAS ]
  • C20H23FN6O2 [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 423768-52-9 ]

Amines

Chemical Structure| 28466-21-9

A780921 [28466-21-9]

1,3,5-Trimethyl-1H-pyrazol-4-amine

Similarity: 0.91

Chemical Structure| 1185303-62-1

A291648 [1185303-62-1]

4-Amino-1,3,5-trimethylpyrazole hydrochloride

Similarity: 0.89

Chemical Structure| 612511-81-6

A906897 [612511-81-6]

(1-Methyl-1H-pyrazol-3-yl)methanamine

Similarity: 0.80

Chemical Structure| 947763-34-0

A179536 [947763-34-0]

1-Ethyl-3-methyl-1H-pyrazol-4-amine

Similarity: 0.80

Chemical Structure| 852227-87-3

A717465 [852227-87-3]

1-(1,3-Dimethyl-1H-pyrazol-5-yl)-N-methylmethanamine

Similarity: 0.79

Related Parent Nucleus of
[ 423768-52-9 ]

Pyrazoles

Chemical Structure| 28466-21-9

A780921 [28466-21-9]

1,3,5-Trimethyl-1H-pyrazol-4-amine

Similarity: 0.91

Chemical Structure| 1072-91-9

A433627 [1072-91-9]

1,3,5-Trimethylpyrazole

Similarity: 0.90

Chemical Structure| 1185303-62-1

A291648 [1185303-62-1]

4-Amino-1,3,5-trimethylpyrazole hydrochloride

Similarity: 0.89

Chemical Structure| 25016-09-5

A470610 [25016-09-5]

1,3-Dimethyl-1H-pyrazole-5-carbaldehyde

Similarity: 0.81

Chemical Structure| 612511-81-6

A906897 [612511-81-6]

(1-Methyl-1H-pyrazol-3-yl)methanamine

Similarity: 0.80